MRTX

Mirati Therapeutics, Inc. Common Stock

Delisted

MRTX was delisted on the 22nd of January, 2024.

51 hedge funds and large institutions have $54.8M invested in Mirati Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

52% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 23

76% less call options, than puts

Call options by funds: $4K | Put options by funds: $17K

Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4K
Puts
$17K
Net Calls
Net Calls Change

Top Buyers

1 +$1.46M
2 +$431K
3 +$391K
4
Millennium Management
Millennium Management
New York
+$366K
5
HP
Hikari Power
Japan
+$365K

Top Sellers

1 -$2.14M
2 -$1.96M
3 -$895K
4
Renaissance Technologies
Renaissance Technologies
New York
-$854K
5
State Street
State Street
Massachusetts
-$721K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$10.5M
2
$9.09M
3
$8.3M
4
$8.28M
5
$3.79M
6
$2.65M
7
$2.38M
8
$1.09M
9
$921K
10
$917K
11
$893K
12
$796K
13
$728K
14
$391K
15
$372K
16
$365K
17
$359K
18
$296K
19
$292K
20
$236K
21
$207K
22
$200K
23
$184K
24
$183K
25
$162K